DuPont licenses its technology

Published: 28-May-2001


DuPont Pharmaceuticals is to license its Cre-lox technology to Bristol-Myers Squibb, Novartis and Pharmacia. Cre-lox is a research tool to help deciphering gene function. DuPont says nine of the world's top 10 pharma companies have now licensed its technology. It has also granted free use to over 250 academic centres to advance research.

You may also like